Vyleesi generic name?

What is the generic name for Vyleesi?

Vyleesi is also known by its generic name bremelanotide, which is an injectable medication used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.

Who makes generic versions of Vyleesi?

Bremelanotide is a relatively new drug, and generic versions of Vyleesi are not yet widely available. As of my knowledge cutoff, the patent for bremelanotide is still active in some countries [1]. However, companies like Amneal Pharmaceuticals are developing their own versions of the drug.

When will generic bremelanotide be available?

The availability of generic bremelanotide will depend on various factors, including the expiration of the patent and regulatory approvals. According to DrugPatentWatch.com, the patent for bremelanotide (Vyleesi) is set to expire in 2033 [2].

What companies are developing biosimilars for Vyleesi?

Several companies, including Sandoz and Teva Pharmaceuticals, are developing biosimilars for Vyleesi. Biosimilars are highly similar versions of biologic drugs, and their development and approval process can take several years.

References:

[1] DrugPatentWatch.com: Bremelanotide (Vyleesi) Patent Expiration Date [Online]. Available at: https://www.drugpatentwatch.com/patent/US10372935/ [Accessed 24 June 2026]

[2] 10372935 - Pharmaceutical Patents (bremelanotide (Vyleesi))